Cargando…
Comparison of Phospholipid-Based Particles for Sustained Release of Ciprofloxacin Following Pulmonary Administration to Bronchiectasis Patients
The rapid clearance of ciprofloxacin hydrochloride from the lungs following administration as an aerosol leads to poor efficacy in the treatment of pulmonary infections. The development of formulations capable of sustaining ciprofloxacin concentrations in the lungs has the potential to significantly...
Autor principal: | Weers, Jeffry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967322/ https://www.ncbi.nlm.nih.gov/pubmed/32026415 http://dx.doi.org/10.1007/s41030-019-00104-6 |
Ejemplares similares
-
Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
por: Chorepsima, Stamatia, et al.
Publicado: (2018) -
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler
por: Son, Yoen-Ju, et al.
Publicado: (2021) -
In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release Formulations
por: Shi, Changzhi, et al.
Publicado: (2023) -
Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment
por: Almurshedi, Alanood S, et al.
Publicado: (2021) -
Novel sustained release and swellable gastroretentive dosage form for ciprofloxacin hydrochloride
por: Gaikwad, Vinay Dhananjay, et al.
Publicado: (2014)